Filing Flows

Filing Flows › Aspira Women's Health (AWHL) › Q3 2025

Aspira Women's Health (AWHL) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 14, 2025

Aspira Women's Health (AWHL) reported revenue of $2.3M for the third quarter 2025 (Q3 2025), +2% from a year earlier and -4% from the quarter before. Operating margin was -68.5%, net loss $4.9M (212.2% of revenue).

Revenue$2.3M
Year over year+2%
Quarter over quarter-4%
Operating margin-68.5%
Net earnings−$4.9M

Aspira Women's Health, Q3 2025: revenue $2.3M (+2% year over year), operating margin -68.5%, net loss $4.9M, operating cash flow −$212K. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$2.3M-4%+2%
Operating profit−$1.6M——
Net earnings−$4.9M——
Operating cash flow−$212K——

What changed

Revenue was $2.3M in Q3 2025, up 2% year over year and down 4% from the previous quarter.

Gross margin was 60.0%, unchanged from a year earlier. Operating costs exceeded revenue by $1.6M, an operating margin of -68.5%. Operating expenses fell 42% while revenue rose 2%. The quarter ended with a net loss of $4.9M, wider than the previous quarter's $2.7M loss. Net interest and other expense of $3.3M was the main reason.

Operating cash flow was −$212K. Non-cash charges added back $50K of depreciation and amortization and $36K of share-based compensation. Working capital and other items added $4.6M.

Questions

What was Aspira Women's Health's revenue in the third quarter 2025?

Aspira Women's Health (AWHL) reported revenue of $2.3M for the third quarter 2025 (Q3 2025), +2% from a year earlier and -4% from the quarter before.

Was Aspira Women's Health profitable in the third quarter 2025?

Operating loss was $1.6M (-68.5% of revenue) and net loss $4.9M.

Open the interactive Sankey →

Source: Aspira Women's Health 10-Q on SEC EDGAR.